ABSTRACT
No disponible
Subject(s)
Humans , Male , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Carcinoma, Basal Cell/drug therapy , Imiquimod/administration & dosage , Skin Neoplasms/drug therapy , Administration, TopicalABSTRACT
No disponible
Subject(s)
Humans , Male , Middle Aged , Urinary Sphincter, Artificial/adverse effects , Urologic Surgical Procedures, Male/methods , Prosthesis FailureSubject(s)
Urinary Sphincter, Artificial/adverse effects , Humans , Male , Middle Aged , Prosthesis FailureABSTRACT
No disponible
Subject(s)
Humans , Male , Aged , Weight Gain/physiology , Magnetic Resonance Spectroscopy/methods , Cysts/pathology , Kidney Pelvis/metabolism , Urinary Retention/metabolism , Urinary Retention/pathology , Weight Gain/genetics , Magnetic Resonance Spectroscopy/standards , Cysts/complications , Kidney Pelvis/pathology , Urinary Retention/complications , Urinary Retention/diagnosisSubject(s)
Cysts/complications , Urinary Bladder Diseases/complications , Urinary Retention/etiology , Abdomen , Aged , Chronic Disease , Humans , MaleABSTRACT
No disponible
Subject(s)
Humans , Male , Adult , Cysts/metabolism , Cysts/pathology , Imaging, Three-Dimensional/methods , Urinary Tract Infections/metabolism , Urinary Tract Infections/urine , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/metabolism , Pelvic Infection/pathology , Cysts/rehabilitation , Cysts/surgery , Imaging, Three-Dimensional/instrumentation , Urinary Tract Infections/complications , Urinary Tract Infections/diagnosis , Prostatic Neoplasms/complications , Prostatic Neoplasms/genetics , Pelvic Infection/metabolismABSTRACT
OBJECTIVES: To study the efficacy and safety of the Perigee® System for the treatment of anterior vaginal prolapse in our experience with a medium term follow-up. METHODS: Prospective analysis on 48 consecutive patients with stage II-IV cystocele diagnosed from June 2006 until June 2009 using the Pelvic Organ Prolapse Quantitation classification without other associated prolapses. All diagnoses were done by a single urological specialist and follow-up is between 3 to 6 years. The questionnaire Patient Global Impression of Improvement was carried out before surgery, at the first follow up checking at one month, and at 6 and 12 months. The variables evaluated were age, presence of obesity, parity, prior hysterectomy, ASA class and stage of prolapse. RESULTS: The result, evaluating the questionnaire Patient Global Impression of Improvement, was cured or improved in 40 (83.3%) patients and 87.5% according to the Pelvic Organ Prolapse Quantitation, with a recurrence rate of 6.25%. Intraoperative complications were observed in 12.5% of the patients, postoperative in 4.2% and 41.5% after hospital discharge, pain being the most common complication (16.6%). The key variables for procedural failure were age 65 years >, obesity, parity ≥ 2, prolapse stage ≥ III and prior hysterectomy (p <0.05). CONCLUSIONS: In our series the Perigee® System allows anatomic repair with less morbidity, hospital stay and recovery time.
Subject(s)
Pelvic Organ Prolapse/surgery , Surgical Mesh , Age Factors , Aged , Cystocele/surgery , Female , Follow-Up Studies , Humans , Intraoperative Complications/epidemiology , Middle Aged , Obesity/complications , Parity , Patient Satisfaction , Postoperative Complications/epidemiology , Prospective Studies , Recurrence , Surveys and Questionnaires , Treatment OutcomeABSTRACT
OBJETIVO: Estudiar la eficacia y seguridad según nuestra experiencia del sistema Perigee® para el tratamiento del prolapso vaginal anterior. MÉTODOS: Análisis prospectivo en 48 pacientes consecutivas diagnosticadas mediante la clasificación para la Pelvic Organ Prolapse Quantification (Cuantificación del Prolapso de órganos Pélvicos) (POP-Q) de cistocele estadios II a IV, sin otros prolapsos asociados, desde Junio de 2006 hasta Junio de 2009, realizados por un único urólogo especializado, con un seguimiento de 3 a 6 años. Se ha realizado el cuestionario Patient Global Impression of Improvement (Impresión Global de Mejora del Paciente) (PGI-I) antes de la cirugía, en el primer control al mes, a los 6 y 12 meses. Se evaluaron las variables edad, presencia de obesidad, número de partos, histerectomía previa, clase ASA y estadio de prolapso. RESULTADOS: El resultado, evaluando el cuestionario Patient Global Impression of Improvement, fue de curación o mejoría en 40 (83,3%) pacientes y según la Pelvic Organ Prolapse Quantitation del 87,5%, con una tasa de recidiva del 6,25%. Se observaron complicaciones intraoperatorias en el 12,5% de las pacientes, postoperatorias en el 4,2%, y postalta en 41,5%, siendo el dolor la complicación más frecuente (16,6%). Las variables determinantes del fracaso del procedimiento, estadísticamente significativas (p <0,05), fueron la edad >65 años, obesidad, número de partos ≥ 2, estadio del prolapso ≥ III e histerectomía previa. CONCLUSIONES: En nuestra serie el sistema Perigee® permite la reparación anatómica con menor morbilidad, estancia hospitalaria y tiempo de recuperación
OBJECTIVES: To study the efficacy and safety of the Perigee® System for the treatment of anterior vaginal prolapse in our experience with a medium term follow-up. METHODS: Prospective analysis on 48 consecutive patients with stage II-IV cystocele diagnosed from June 2006 until June 2009 using the Pelvic Organ Prolapse Quantitation classification without other associated prolapses. All diagnoses were done by a single urological specialist and follow-up is between 3 to 6 years. The questionnaire Patient Global Impression of Improvement was carried out before surgery, at the first follow up checking at one month, and at 6 and 12 months. The variables evaluated were age, presence of obesity, parity, prior hysterectomy, ASA class and stage of prolapse. RESULTS: The result, evaluating the questionnaire Patient Global Impression of Improvement, was cured or improved in 40 (83.3%) patients and 87.5% according to the Pelvic Organ Prolapse Quantitation, with a recurrence rate of 6.25%. Intraoperative complications were observed in 12.5% of the patients, postoperative in 4.2% and 41.5% after hospital discharge, pain being the most common complication (16.6%). The key variables for procedural failure were age 65 years >, obesity, parity ≥ 2, prolapse stage ≥ III and prior hysterectomy (p <0.05). CONCLUSIONS: In our series the Perigee® System allows anatomic repair with less morbidity, hospital stay and recovery time
Subject(s)
Humans , Female , Pelvic Organ Prolapse/surgery , Cystocele/surgery , Urinary Incontinence, Stress/surgery , Surgical Mesh , Prospective Studies , Treatment Outcome , Patient Satisfaction , Risk Factors , Obesity/complications , Reproductive HistoryABSTRACT
A 73 year-old patient with history of arterial hypertension and regular treatment with antiplatelet agents who presented with an hypotensive episode after extracorporeal shock-wave lithotripsy (ESWL) was diagnosed of right renal hematoma.
Subject(s)
Hematoma , Lithotripsy , Humans , Hypertension , Kidney , Kidney Calculi , Kidney DiseasesABSTRACT
No disponible